Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination : a population-based matched cohort study
© 2023. Springer Nature Limited..
Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Nature communications - 14(2023), 1 vom: 29. Aug., Seite 5275 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lindsay, Laura [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 31.08.2023 Date Revised 14.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-023-40965-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361419104 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361419104 | ||
| 003 | DE-627 | ||
| 005 | 20240214232757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-023-40965-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM361419104 | ||
| 035 | |a (NLM)37644002 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lindsay, Laura |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination |b a population-based matched cohort study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2023 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Springer Nature Limited. | ||
| 520 | |a Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16-1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20-3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39-2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47-4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Calvert, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Carruthers, Jade |e verfasserin |4 aut | |
| 700 | 1 | |a Denny, Cheryl |e verfasserin |4 aut | |
| 700 | 1 | |a Donaghy, Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Hopcroft, Lisa E M |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, Leanne |e verfasserin |4 aut | |
| 700 | 1 | |a Goulding, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a McLaughlin, Terry |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Taylor, Bob |e verfasserin |4 aut | |
| 700 | 1 | |a Bhaskaran, Krishnan |e verfasserin |4 aut | |
| 700 | 1 | |a Katikireddi, Srinivasa Vittal |e verfasserin |4 aut | |
| 700 | 1 | |a McCabe, Ronan |e verfasserin |4 aut | |
| 700 | 1 | |a McCowan, Colin |e verfasserin |4 aut | |
| 700 | 1 | |a Simpson, Colin R |e verfasserin |4 aut | |
| 700 | 1 | |a Robertson, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Sheikh, Aziz |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, Rachael |e verfasserin |4 aut | |
| 700 | 1 | |a Stock, Sarah J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 14(2023), 1 vom: 29. Aug., Seite 5275 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:1 |g day:29 |g month:08 |g pages:5275 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-023-40965-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 1 |b 29 |c 08 |h 5275 | ||